LAM
L2 Asset Management’s United Therapeutics UTHR Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.57M | Sell |
8,945
-4,952
| -36% | -$1.42M | 0.42% | 68 |
|
|
2025
Q1 | $4.28M | Buy |
13,897
+1,320
| +10% | +$407K | 0.88% | 40 |
|
|
2024
Q4 | $4.44M | Buy |
12,577
+2,570
| +26% | +$907K | 0.96% | 35 |
|
|
2024
Q3 | $3.59M | Buy |
10,007
+7,643
| +323% | +$2.74M | 0.97% | 31 |
|
|
2024
Q2 | $753K | Buy |
2,364
+300
| +15% | +$95.6K | 0.23% | 85 |
|
|
2024
Q1 | $474K | Buy |
2,064
+79
| +4% | +$18.1K | 0.16% | 105 |
|
|
2023
Q4 | $436K | Buy |
1,985
+1,406
| +243% | +$309K | 0.18% | 99 |
|
|
2023
Q3 | $1.43M | Sell |
579
-11,438
| -95% | -$28.2M | 0.67% | 48 |
|
|
2023
Q2 | $2.65M | Buy |
12,017
+1,563
| +15% | +$345K | 1.3% | 27 |
|
|
2023
Q1 | $2.34M | Sell |
10,454
-138
| -1% | -$30.9K | 1.29% | 21 |
|
|
2022
Q4 | $2.95M | Buy |
10,592
+13
| +0.1% | +$3.62K | 1.83% | 11 |
|
|
2022
Q3 | $2.22M | Buy |
+10,579
| New | +$2.22M | 1.52% | 21 |
|